Issued Patents All Time
Showing 1–25 of 81 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12226429 | Highly active compounds against COVID-19 | Adel Moussa | 2025-02-18 |
| 12134588 | Crystalline epinephrine malonate salt | Adel Moussa | 2024-11-05 |
| 12084473 | β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment | Adel Moussa | 2024-09-10 |
| 12006340 | Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus | Adel Moussa | 2024-06-11 |
| 11975016 | 2′-substituted-N6-substituted purine nucleotides for RNA virus treatment | Adel Moussa | 2024-05-07 |
| 11813278 | Highly active compounds against COVID-19 | Adel Moussa | 2023-11-14 |
| 11738038 | Highly active compounds against COVID-19 | Adel Moussa | 2023-08-29 |
| 11707480 | Highly active compounds against COVID-19 | Adel Moussa | 2023-07-25 |
| 11690860 | Treatment of HCV infected patients with cirrhosis | Adel Moussa, Keith M. Pietropaolo, Xiao-Jian Zhou | 2023-07-04 |
| 11505521 | Crystalline epinephrine malonate salt | Adel Moussa | 2022-11-22 |
| 10995059 | Crystalline epinephrine malonate salt | Adel Moussa | 2021-05-04 |
| 10946033 | 2′-substituted-N6-substituted purine nucleotides for RNA virus treatment | Adel Moussa | 2021-03-16 |
| 10906928 | Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus | Adel Moussa | 2021-02-02 |
| 10894804 | Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus | Adel Moussa | 2021-01-19 |
| 10874687 | Highly active compounds against COVID-19 | Adel Moussa | 2020-12-29 |
| 10875885 | β-d-2′-deoxy-2′-α-fluoro-2′-β-c-substituted-2-modified-n6-substituted purine nucleotides for HCV treatment | Adel Moussa | 2020-12-29 |
| 10870673 | β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment | Adel Moussa | 2020-12-22 |
| 10870672 | β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment | Adel Moussa | 2020-12-22 |
| 10815266 | β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment | Adel Moussa | 2020-10-27 |
| 10758557 | Methods and compositions for treating hepatitis C virus | Paolo La Colla | 2020-09-01 |
| 10711029 | Beta-d-2′-deoxy-2′-alpha-fluoro-2′-beta-c-substituted-4′fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection | Adel Moussa | 2020-07-14 |
| 10525072 | 2′-branched nucleosides and flaviviridae mutation | Paolo La Colla, David Standring, Vadim Bichko, Lin Qu | 2020-01-07 |
| 10519186 | Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus | Adel Moussa | 2019-12-31 |
| 10363265 | Methods and compositions for treating hepatitis C virus | Paolo La Colla | 2019-07-30 |
| 10239911 | Beta-D-2′-deoxy-2′-alpha-fluoro-2′-beta-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment | Adel Moussa | 2019-03-26 |